972 2 6426741 mail.
Ms stem cells dr d karussis.
Born in salonika greece he has lived in israel since 1988 researched bone marrow stem cells since 1990 and now heads hadassah s multiple sclerosis center.
T cell vaccination tcv for multiple sclerosis ms refers to treatment with autologous anti myelin t cells attenuated by irradiation.
Stem cell derived neural progenitors as a fea sible source of stem cells for central nervous system applications in multiple sclerosis.
Professor dimitrios karussis mesenchymal stem cell transplantation in ms.
This study aimed to evaluate the safety and efficacy of transplantation of autologous msc transplantation in active progressive ms.
Stem cells hold key signals helping to keep your skin looking youthful.
Rey brings you the latest in stem cell technology.
Bulte t ben hur s.
Multiple sclerosis was however the first focus for dr.
Dimitrios karussis professor in neurology.
Neurology residency in the department of neurology hadassah university hospital.
Stem cell therapy trial for als and ms patients at jerusalem hospital shows stunning results it is a matter of definitely less than 10 years maybe less than five that we can have this treatment.
Stem cells transl med 2012.
Click for more information.
At the limits gavin giovannoni mesenchymal stem cell multiple sclerosis professor dimitrios karussis stem cell nutrition.
Previously published clinical trials have been all open.
Full professor of neurology hebrew university fax.
Medicine m d aristotelion university medical school thessaloniki greece 1990 1994.
Our department at hadassah is one of the leading stem cell research centers in the world he says.
The hadassah medical center is continuing to receive positive findings with its phase ii clinical trial using its unique stem cell approach to stop the progression and reversing the disabilities of multiple sclerosis.
Mesenchymal stem cells msc induce immune modulatory and neurotrophic effects and are safe when administered to patients with multiple sclerosis ms or amyotrophic lateral sclerosis als.
Pilot phase i ii clinical trial with autologous bone marrow derived mesenchymal stromal stem cells in patients with multiple sclerosis and amyotrophic lateral sclerosis archives of neurology 2010 67 10 1187 119.
